| Date | Title | Description |
| 08.10.2024 | Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System | Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
Underlying proof of rejuvenative healing indicative of airway remodeling corresponds wi... |
| 10.09.2024 | CSA Medical's $53 Million Boost: A Breath of Fresh Air for Chronic Bronchitis Treatment | In the bustling world of medical innovation, CSA Medical has just made waves. The Boston-based company recently secured $53 million in Series D funding. This investment is not just a number; it represents hope for countless patients sufferi... |
| 09.09.2024 | CSA Medical Raises $53M in Series D Financing | RejuvenAir Metered Cryospray
CSA Medical, a Boston, Ma-based developer of The RejuvenAir® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, raised $53M in Series D funding.
The rou... |
| 09.09.2024 | CSA Medical: $53 Million (Series D) Raised For Advancing RejuvenAir System | CSA Medical, the developer of The RejuvenAir System (a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis), announced the completion of an oversubscribed $53 million ... |
| 12.05.2021 | CSA Medical Announces Completion of Enrollment in Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis | |
| 23.11.2020 | CSA Medical Announces Metered Cryospray with the RejuvenAir® System for the treatment of Chronic Bronchitis Featured at the 21st World Congress of Bronchology and Interventional Pulmonology | |
| 11.11.2020 | CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis | |
| 09.10.2018 | CSA Medical Secures $23M in Funding | CSA Medical Inc., a Lexington, Massachusetts-based developer of two novel cryospray therapy platforms, truFreeze and Rejuvenair, secured $23m in venture debt and equity financing.
Horizon Technology Finance provided a $15m venture loan faci... |
| 08.10.2018 | CSA Medical Secures $23 Million to Advance its Cryospray™ Therapies for Esophageal Disease and COPD | - |
| 08.10.2018 | CSA Medical Secures $23 Million | CSA Medical Inc. announced that it has secured $23 million in venture debt and equity financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair. Horizon Technology Finance (Horizon) provided the $15 million ve... |
| 21.07.2015 | 5 noteworthy Baltimore-area investment deals from Q2 2015 | The second three months of 2015 brought a 30 percent increase in venture capital deals nationwide, with software companies seeing the biggest investment to the tune of $7.3 billion.
Maryland mirrored the first part of that trend, but contin... |
| 20.04.2015 | CSA Medical raises another $4m for cryotherapy device | Maryland’s CSA Medical said last week that it’s close to reaching a $4 million funding goal with a new debt offering.
CSA’s main product is its truFreeze spry cryotherapy, which is designed to use super-cold liquid nitrogen delivered via ca... |
| 16.04.2015 | A step up from Dr. Scholl’s: Baltimore devicemaker raises $2.9M for cryotherapy that freezes off malignant internal tissue | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 15.01.2014 | CSA Medical Inc. raises $16M in equity [Startup Roundup] | Have news for the Startup Roundup? Get in touch.who’s getting funded?
CSA Medical Inc, based Lutherville, Md., has raised $16 million in equity, according to SEC filings. The healthcare company develops a freezing spray cryotherapy technolo... |
| 31.12.2013 | CSA Medical closes $16M financing round | CSA Medical said it raised $16 million, closing a series C financing round led by Ascension Ventures.
The Baltimore-based medical device company manufactures advanced spray cryotherapy technology that flash freezes unwanted tissue inside th... |
| 23.12.2013 | CSA Medical Completes $16M Series C |
BALTIMORE, MD, Leading provider of advanced spray cryotherapy technology that flash freezes unwanted tissue inside the body, today announced that it has closed a $16 million Series C financing.
>> Click here for more funding data o... |
| 22.12.2013 | CSA Medical Closes $16M Series C Financing | CSA Medical, Inc., a Lutherville, Maryland-based provider of advanced spray cryotherapy technology, closed a $16m Series C financing.
The round was led by Ascension Ventures (AV) with participation from existing investors SV Life Sciences, ... |
| 20.12.2013 | CSA Medical Completes $16 Million Series C Financing | - |
| 19.12.2011 | InVivo readies $10M round | Funding Roundup | Spinal injury therapy maker InVivo Therapeutics Holdings Corp. (OTC:NVIV) is preparing a $10 million offering, SEC filings show.
Details haven’t yet been made public regarding pricing, but the company expects to use the proceeds for researc... |
| 15.12.2011 | CSA Medical Raises $20.5M in Series B Funding | CSA Medical, Inc., a Baltimore, Maryland-based developer of novel Spray Cryotherapy devices that freeze and destroy unwanted tissue inside the body, has secured $20.5m in a Series B financing.
The round was led by Intersouth Partners and Fi... |
| 12.07.2011 | CSA Medical Completes $12.6 Million Series A |
Proceeds from the financing will be used to address customer demand and support the launch of CSA Medical's new platform technology.
>> Click here for more funding data on CSA Medical
>> To export CSA Medical funding data to... |
| 25.01.2011 | CSA Medical Secures $10M in Series A Financing | CSA Medical, Inc., a Baltimore, Maryland-based developer of spray cryotherapy technologies that enable precise delivery of liquid nitrogen to treat diseased tissue, has secured $10m in a Series A financing.
The company intnds to use the cap... |
| 21.06.2007 | CSA Medical pulls in $8.3M for tissue-ablation device | CSA Medical, a Baltimore developer of endoscopic cryoablation systems, raised $8.3 million in a first round of funding, VentureWire reports (subscription required). New Markets Growth Fund and angel investors provided the funding.
CSA Medic... |
| - | A step up from Dr. Scholl’s: Baltimore devicemaker raises $2.9M for cryotherapy that freezes off malignant internal tissue | A well-funded Baltimore startup whose spray cryotechnology flash-freezes unwanted or malignant tissues inside the body just raised a touch more capital.
According to a regulatory filing, CSA Medical just raised $2.9 million – on top of the ... |
